NCT03721796View on ClinicalTrials.gov

Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions

TerminatedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

May 26, 2019

Primary Completion Date

March 16, 2020

Study Completion Date

March 16, 2020

Conditions
Newly Diagnosed Cancer Patients Who Are HIV Positive and Their Treating Oncologist
Interventions
OTHER

Audio recording of initial consultation and debriefing interviews.

Semi-structured debriefing interviews with participating oncologists and HIV-infected newly diagnosed cancer patients will follow the initial encounter. Interviews will be conducted over 45-60 minutes and will be semi-structured with open-ended questions to allow the interviewee to direct the flow of the conversation.

Trial Locations (1)

27710

Duke Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER

NCT03721796 - Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions | Biotech Hunter | Biotech Hunter